CLINICAL_TRIALS
trial_result
· 2023-05-24
Clinical Trial Update: Atezolizumab Immunotherapy in Patients With Advanced NSCLC [Phase 2]
Summary
Phase 2 clinical trial update of atezolizumab immunotherapy in patients with advanced non-small cell lung carcinoma; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance Foundation Trials, LLC. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24